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Previous work has examined the use of mitochondrial DNA (mtDNA) damage as a biomarker of cumulative sun
exposure in human skin. These studies have simply compared mtDNA damage between sun-protected and sun
exposed skin. This approach is limited because non-melanoma skin cancer (NMSC) is predominantly formed on
body sites which are ‘usually’ sun exposed as opposed to sites which are ‘occasionally’ sun exposed and as such
they differ in their cumulative ultraviolet (UV) exposure. This study addresses this limitation by investigating the
frequency of occurrence of a rarely reported 3895 bp mtDNA deletion in 104 age-matched human skin samples
taken from different sun-exposed body sites. There was a significant increase in the deletion frequency with
increasing UV exposure (po0.0001). Furthermore there was a significantly greater deletion frequency in ‘usually’
sun exposed compared with ‘occasionally’ sun-exposed body sites in both the dermis (p¼ 0.0018) and epidermis
(po0.0001). Investigation of the 3895 bp deletion in the same NMSC samples used in a previous study of the 4977
bp common deletion, showed a greater frequency of the 3895 bp deletion (8/10 vs 4/10, respectively). Additionally,
we have linked the 3895 bp deletion with the UVR component of sunlight by inducing the deletion in vitro with
repetitive sub-lethal doses of a UVAþUVB light source.
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The incidence of non-melanoma skin cancer (NMSC) is
increasing in populations of European origin (Severi and
English, 2004), e,g., 1 million new cases diagnosed each
year in the USA (Wesson and Silverberg, 2003) and 65,000
in the UK (figures provided by Cancer Research, UK).
NMSC accounts for around 90% of skin cancers and con-
sists of basal cell and squamous cell carcinomas (BCC and
SCC, respectively). BCC are the commonest form of NMSC
and arise predominantly from the basal keratinocytes of the
epidermis but also from cells in hair follicles and sebaceous
glands. They are locally invasive but rarely metastasize.
SCC are also derived from basal keratinocytes; however, in
contrast to BCC, SCC may metastasize. Compared with
BCC, SCC shows the greatest increase with age and is
concentrated in the elderly (Severi and English, 2004). The
relative density of NMSC is highest on body sites ‘‘usually’’
exposed to the sun when outdoors such as scalp, face,
neck, and ears as defined by Armstrong (2004). SCC, how-
ever, differs appreciably from BCC in having a much lower
density on body sites which are ‘‘occasionally’’ exposed to
the sun such as shoulders, back, and chest as defined by
Armstrong (2004).
Therefore, the major determinant of NMSC is the ultra-
violet radiation (UVR) component of sunlight that induces
DNA damage. Importantly it is both the pattern (more con-
tinuous vs intermittent) and the cumulative amount of sun
exposure that influences the development of NMSC (Arm-
strong and Kricker, 2001). To determine a reliable marker of
cumulative UVR exposure in human skin, our research
group and others have examined the novel idea of using
mitochondrial DNA (mtDNA), rather than nuclear DNA, as a
biomarker of UV-induced DNA damage (Pang et al, 1994;
Berneburg et al, 1997; Birch-Machin et al, 1998; Birch-Ma-
chin, 2000). Compared with mutation screening of nuclear
DNA genes such as p53, there are certain advantages of
studying mtDNA damage in sun-exposed skin. First, al-
though there is evidence in mitochondria for base excision
repair of oxidative damage, there is no evidence of nuclear
excision repair for the repair of DNA photoproducts (e.g.,
cyclobutane pyrimidine dimers) in mtDNA (LeDoux et al,
1993; Croteau and Bohr, 1997; Pascucci et al, 1997; Sawyer
and Van Houten, 1999). Second, each cell can contain up to
several thousand copies of the mtDNA genome and mi-
tochondria can therefore tolerate very high levels (up to
90%) of damaged mtDNA through complementation of the
remaining wild-type (Chomyn et al, 1992; Sciacco et al,
1994). Together, these factors lead to accumulation of pho-
todamage in mtDNA without compromising cell function.
The use of mtDNA damage as a biomarker for cumulative
sun exposure in human skin is a relatively new field of re-
search and previous work has simply compared mtDNA
damage to distinguish between sun-protected and sun-
exposed skin (Pang et al, 1994; Berneburg et al, 1997;1These authors contributed equally to this study.
Abbreviations: BCC, basal cell carcinoma; mtDNA, mitochondrial
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Birch-Machin et al, 1998). This approach is limited because
NMSC is predominantly formed on body sites which are
‘‘usually’’ exposed to the sun when outdoors as opposed to
sites that are ‘‘occasionally’’ exposed to the sun (Armstrong,
2004). In an attempt to address this limitation, the present
study shows that the frequency of occurrence of a rarely
reported 3895 bp mtDNA deletion (only previously de-
scribed in diseased muscle (Moraes et al, 1992)) is signif-
icantly different between body sites that are ‘‘usually’’
versus ‘‘occasionally’’ exposed to the sun. In addition, we
have furthered the link between the etiology of the 3895 bp
deletion with the UVR component of sunlight by inducing
the 3895 bp deletion in vitro with repetitive sub-lethal doses
of a UVAþUVB light source.
Results and Discussion
Conﬁrming the identity of the 3895 bp deletion We re-
analyzed in greater detail the mtDNA deletion spectrum of
NMSC and sun-exposed skin from a previous study (Dur-
ham et al, 2003) and found that many samples harbored a
deletion approximately 4 kb in size. Following a search of
the MITOMAP (Mitomap, 2004) database, we postulated
that the identity of this deletion may be the 3895 bp species
that has been reported in the minor arc spanning nucleo-
tides 547–4443. This deletion has previously been associ-
ated with Kearns Sayre Syndrome and Chronic Progressive
External Opthalmoplegia (Moraes et al, 1995). To confirm
the identity of the deletion, we designed a deletion specific
PCR assay (see methods). The 375 bp product from this
PCR was sequenced to confirm that it contained the
deletion-junction sequence that is characteristic of
the 3895 bp deletion, namely 50 CTAACC536 bp/4430 bpcca-
taccccgaa548 bp/4442 AATGTT 30. Characteristically, this se-
quence contained only one of the two 12 bp repeats that
flank the 3895 bp deletion in wild-type mtDNA (lower case
letters).
A comparison of the frequency of the 3895 bp deletion
in body sites which are usually sun exposed versus
those which are occasionally exposed As the 3895 bp
deletion was originally observed in NMSC samples taken
from sun-exposed sites, we addressed the question of
whether the frequency of the deletion is a marker of in-
creasing cumulative sun exposure. Using the deletion-
specific PCR assay (see Materials and Methods), we inves-
tigated its frequency of occurrence in 104 age-matched,
split human skin samples taken from usually, occasionally
and rarely sun-exposed body sites. There was a significant
increase in the deletion frequency with increasing UV ex-
posure in both the epidermis (po0.0001, w2¼31.36, 2 df;
Pearson’s w2 test) and dermis (po0.0001, w2¼ 28.68, 2 df)
(Fig 1). Importantly, there was a significantly greater deletion
frequency in body sites that are ‘‘usually’’ sun-exposed
compared to those which are ‘‘occasionally’’ exposed in
both the dermis (p¼0.0018, w2¼ 9.72, odds ratio 8.5; w2
test) and epidermis (po0.0001, w2¼17.53, odds ratio 40)
(Fig 1b). The deletion was not detected in the body sites that
were ‘‘rarely’’ sun-exposed (Fig 1b). As the mean ages, sex
ratios and tumor type from which the perilesional skin was
taken were very similar between the usually sun-exposed
and occasionally exposed groups (see Materials and Meth-
ods), our findings are unlikely to be confounded by these
factors. In addition, there was no statistical difference in the
mean age values of those samples that harbored (i.e., mean
¼ 66.95  2.84) and did not harbor (mean¼65.81  3.47)
the 3895 bp deletion (p¼ 0.80, t test (Welch correction)).
The 3895 bp mtDNA deletion in NMSC Investigation of
the 3895 bp deletion in the same NMSC samples, which
were used in a previous study of the 4977 bp common
deletion (Durham et al, 2003), showed a comparatively
greater frequency of occurrence of the 3895 deletion (8/10
vs 4/10, respectively), although this difference was not sta-
tistically significant. As these tumors were excised from
body sites that are usually exposed to the sun, it is inter-
esting to speculate that the 3895 bp deletion may be a more
sensitive marker of cumulative sun exposure than the
common deletion.
Figure1
An increased frequency of occurrence of the 3895 bp deletion is
observed with increasing sun exposure. (a) A representative et-
hidium bromide stained, agarose gel showing a greater frequency of
the 3895 bp deletion in body sites that are usually exposed (upper
panel) to the sun when outdoors as opposed to those which are oc-
casionally sun-exposed (lower panel). D, dermis and E, epidermis. The
positive control represents a sample with the 3895 bp deletion that has
been confirmed by sequencing. Lane 1 in both panels represents mo-
lecular weight markers (Hyperladder IV—range 1000–100 bp, Bioline,
London, UK). The same amount of template DNA was added to each
PCR reaction. (b) The histogram shows the frequency of the 3895 bp
deletion in 104 split skin samples taken from different sun-exposed
body sites.
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Historically, it has been assumed that the minor arc re-
gion of the mitochondrial genome that contains the 3895 bp
deletion does not harbor as many deletions as the major arc
that contains the common deletion (Wei et al, 1996; Mito-
map, 2004). As a result, the majority of previous studies
have tended to focus on the spectrum of deletions in the
major arc region. It could be due to this ‘‘research bias’’ that
the 3895 bp deletion has a low reported incidence in the
general literature. Alternatively, the 3895 bp deletion may
naturally occur at currently undetectable levels in normal
tissues, which is then enriched in the skin through exposure
to UV.
Absence of the 3895 bp mtDNA deletion in blood The
3895 bp deletion has only previously been reported in dis-
eased muscle (Moraes et al, 1992). Apart from the present
study in skin, the frequency of occurrence in other tissues is
unknown. We therefore investigated the deletion frequency
in blood, by performing the deletion-specific PCR on 16
blood samples taken from patients of a similar age group to
those of the skin samples. None of the blood samples were
shown to harbor the deletion (data not shown).
Generation of the 3895 bp deletion in cultured HaCaT
cells by repetitive UV irradiation To assess the causal
relationship between the cumulative amount of sun expo-
sure and the frequency of occurrence of the 3895 bp de-
letion, it was necessary to investigate the effect of sunlight
in vitro. As sunlight contains both UVA and UVB, an he-
larium lamp (Diffey, 2002) was used to provide an extensive
series of repetitive sub-lethal UVR dose regimes in an at-
tempt to generate the 3895 bp deletion in a human epider-
mal-derived (HaCaT) cell line. The optimal UVR repetitive
dose strategy was one in which the deletion was generated
without a significant degree of cell death. Using a radioac-
tive PCR-based assay, we demonstrated that the first signs
of induction of the 3895 bp deletion in adherent cells was
observed following 17 alternate daily doses of 0.5 J per cm2
(i.e., 1 SED) of UVR (Fig 2). Furthermore, as sub-lethal UVR
doses were used, the level of the deletion was maintained in
the cell line following two subsequent UV doses, a property
that is important if the 3895 bp can be used as a putative
cumulative biomarker of sun exposure in human skin. This is
of interest given the very recent findings of Berneburg et al
(2004) (published during manuscript revision), who have
demonstrated in vivo that the UVA-induced common dele-
tion may be present 16 months following cessation of
irradiation.
Our observations described above are important for sev-
eral reasons. Firstly, our study has used a UVR source
emitting both UVA and UVB thereby representing more
closely a solar-simulated UVR source than those previous
studies which generated the common deletion using UVA
alone (Berneburg et al, 1999; Koch et al, 2001). Secondly,
this is the first time a deletion other than the 4977 bp com-
mon deletion has been generated by repetitive doses of
UVR. Furthermore, in contrast to the Berneburg study that
utilized fibroblasts, our experiments have been performed
on a cell line derived from keratinocytes and it is this cell
type that gives rise to NMSC.
Functional significance The regions that are deleted in
the 3895 bp deletion are from the mtTF1 binding site in the
D-loop to tRNA methionine. Deleted genes include 12s
rRNA, 16s rRNA, ND1, and also the promoters for tran-
scription of both the H and L strands. A certain threshold of
wild-type:deleted mtDNA must be achieved before an im-
pairment of mitochondrial respiratory function is observed
(Sciacco et al, 1994). For protein-coding mtDNA genes,
such as those removed by the 3895 bp deletion, the thresh-
old value for mitochondrial respiratory chain dysfunction is
around 65% and above (Hayashi et al, 1991; Chomyn et al,
1992). For example, our previous work has shown that hu-
man skin samples harboring o25% of the 4977 bp mtDNA
common deletion, do not exhibit a deficiency of mi-
tochondrial function as determined by dual histochemical
staining of cytochrome oxidase and succinate de-
hydrogenase activities.2 Since there is no functional histo-
chemical stain for the 3895 bp deletion, we attempted to
quantify the deletion in our patient samples using Southern
analysis. In the presence of appropriate controls, this anal-
ysis failed to detect the presence of the 3895 bp deletion
thereby suggesting that the levels of the deletion are below
2%–5% (results not shown). Therefore, based on our pre-
vious work with the common deletion, the levels of the 3895
bp deletion in our patient samples are unlikely to cause any
functional effect across the entire dermis or epidermis,
although small focal effects cannot be ruled out.
Putative mechanism It has previously been suggested that
the mechanism for the generation of the common deletion
involves intragenomic recombination event via slipped-
strand mispairing and may occur at the 13 bp repeat DNA
sequences flanking the common deletion (Schon et al, 1989;
Shoffner et al, 1989; Mita et al, 1990; Degoul et al, 1991). As
the 3895 bp deletion is flanked by 12 bp repeats, its gen-
eration may occur by a similar mechanism. The mechanism
for the generation of the common deletion proposes that the
13 bp repeats are susceptible to DNA bending thereby al-
Figure2
The helarium lamp (UVA/UVB) induces the 3895 bp deletion in Ha-
CaT cells after 17 doses of 0.5 J per cm2 UVR. HaCaT cells were
irradiated with 0.5 J per cm2 (i.e., 1 SED) of UVA/UVB every other day
for a total of 19 doses. Total cellular DNA was extracted from adherent
cells and 100 ng was subjected to PCR to amplify the 3895 bp deletion.
The first signs of a UV-inducible increase of the 3895 bp deletion was
observed following 17 repetitive doses of UVR. The positive control is
DNA from a tumor sample harboring the 3895 bp deletion, whereas the
negative control does not contain DNA.
2Durham S, Betts J, Birch-machin, M. Histochemical and mu-
tational analysis of mitochondrial function and DNA in tumours and
matched normal human skin. Br J Dermatol 733, 2002 (abstr).
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lowing a small region or ‘‘bubble’’ of single-stranded DNA to
open (Schon et al, 1989). Our results suggest that UVR may
be a contributing factor in the generation of the 3895 bp
deletion. The mechanism for this may occur by directly or
indirectly affecting the structurally labile sites in the 12 bp
repeats through opening a ‘‘bubble’’ of single-stranded DNA
that would enhance the recombination event.
Conclusion
In summary, due to limitations by our own previous studies
and others, we have shown that the frequency of a rarely
reported 3895 bp-mtDNA is significantly different between
body sites that are ‘‘usually’’ versus ‘‘occasionally’’ exposed
to the sun when outdoors. Investigation of the 3895 bp de-
letion in the same NMSC samples used in a previous study
of the 4977 bp common deletion showed a comparatively
greater frequency of occurrence of the 3895 bp deletion. In
addition, we have furthered the link between the etiology of
the 3895 bp deletion with the UVR component of sunlight by
inducing the 3895 bp deletion in vitro with repetitive sub-
lethal doses of a UVAþUVB light source. The frequency of
the 3895 bp deletion in human skin provides a potential
biomarker for cumulative UV exposure in human skin and
may in turn provide an early detection tool for NMSC de-
velopment as well as providing a method of monitoring
long-term safety of clinical UV phototherapy regimes.
Materials and Methods
Patient samples Clinically normal perilesional skin from body
sites that are ‘‘usually’’ exposed to the sun when outdoors (such as
scalp, face, neck and ears) (epidermis n¼ 21, dermis n¼ 21, mean
age  SEM¼ 69.4  2.6) and body sites that are ‘‘occasionally’’
exposed to the sun (shoulders, back and chest) (epidermis n¼ 21,
dermis n¼ 21, mean age  SEM¼ 63.1  3.6) were taken with in-
formed consent from 42 NMSC patients attending the skin cancer
excision clinic at the Royal Victoria Infirmary, Newcastle, UK. There
are no significant age differences between the usually and occa-
sionally sun-exposed groups (p¼ 0.158: two-tailed t test (Welch
correction)). In addition, of the 42 patients, the percentage of fe-
males:males were almost the same (i.e., 52%:48%, respectively)
as well as the percentage of BCC and SCC, with 57% of the pa-
tients having a BCC. Normal skin samples from body sites that are
rarely exposed to the sun (such as buttock and heel) were taken
from previously obtained postmortem samples (epidermis n¼ 10,
dermis n¼ 10, mean age¼ 73 y). Epidermis and dermis were sep-
arated using 0.25% dispase at 41C overnight (Durham et al, 2003)
and DNA was extracted using a Qiagen, (Qiagen Ltd, Crawley,
West Sussex, UK) DNeasy tissue extraction kit. Epidermal tumors,
BCC (n¼ 5), SCC (n¼ 5) were obtained from patients attending for
cancer excision. None of the patients used for this study had a
mtDNA defect. This study was performed with full approval of the
host institution (University of Newcastle) and in complete adher-
ance to the Helsinki Principles.
UV irradiation of HaCaT cells A spontaneously immortalized
keratinocyte cell line (HaCaT) (Boukamp et al, 1988) was grown in
Dulbecco’s modified Eagle’s medium containing, 10% fetal bovine
serum 5 IU per mL penicillin and 5 g per mL streptomycin. The cells
were grown to 70%–90% confluency in a 9 cm diameter tissue
culture-treated Petri dishes, washed in PBS and then irradiated
every alternate day with a sub-lethal dose (0.5 J per cm2 which
is equivalent to 1 SED) of UVR using an helarium 40 W lamp
(Wolff B1.01, 290–400 nm, peak emission at 325 nm) (Helarium,
Cosmetico, Stuttgart, Germany). At appropriate time points, total
cellular DNA was extracted from the adherent cells using the Qia-
gen, DNeasy tissue extraction kit.
PCR analysis The PCR was carried out in a 25 mL reaction con-
taining 200 ng genomic DNA, 600 nM of each primer, 250 mM
dNTPs, 0.6 U per reaction Amplitaq Gold DNA polymerase (Applied
Biosystems Warrington, Cheshire, UK), GeneAmp buffer (contain-
ing, 100 mM Tris-HCl, pH 8.3, 500 mM KCl, 15 mM MgCl and 0.01%
(wt/vol) gelatin). The PCR primers used were L404 (50 CTT TTG GCG
GTA TGC ACT TT 30) (404–423 nt) and H4676 (50 GAT TAT GGA TGC
GGT TGC TT 30) (4676—4657 nt). Primers L404 and H4676 were
designed to anneal outside the 3895 bp deletion. During DNA am-
plification the short (30 s) polymerase extension time did not permit
amplification of wild-type PCR products, allowing only amplification
of the smaller 375 bp product which represents the deleted mtDNA
species. The PCR conditions were 941C for 10 min, 35 cycles of
941C for 30 s, 561C for 30 s, 721C for 30 s, and a final extension of
7 min at 721C. Amplification products were visualized in a 1% ag-
arose gel stained with ethidium bromide (0.25 mg per mL).
DNA sequence analysis The 375 bp PCR product was gel ex-
cised and purified using QIAquick gel extraction kit (Qiagen Ltd.,
Crawley, West Sussex, UK) and cloned into a pCR4-TOPO vector
using a TOPOTA Cloning kit (Invitrogen, Paisley, Scotland, UK). To
confirm the identity of the 375 bp PCR product, the DNA was
sequenced using automated DNA sequencing (MWG Biotech,
Ebersberg, Germany).
Radioactive PCR analysis To detect low levels of the deletion
generated by UVR, the PCR was carried out as described above but
with addition of 3 mCi of [a-32P]-dCTP (Amersham, Buckingham-
shire, UK). The PCR products were then electrophoresed through a
6% non-denaturing polyacrylamide gel and exposed to a phos-
phorimage screen for approximately 24 h. The radioactive PCR
fragments were scanned and visualized by a Phosphorimager, using
the ImageQuant software (Molecular Dynamics, Chesham, UK).
Statistical analysis Statistical analyses were performed using
StatCalc (Epi-info. CDC, Alberta, Georgia) employing w2, Pearson’s
w2, Fisher’s exact and paired t tests.
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